Xiaoyi Huang1, Fengxiang Wei2, Liang Hu2, Lijuan Wen2, Ken Chen1. 1. School of Nursing, Guangdong Pharmaceutical University, 283 Jianghai Avenue, Haizhu District, Guangzhou, China. 2. Shenzhen Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen 518172, China.
Abstract
Since December 2019, there has been an outbreak of a novel coronavirus (COVID-19) infection in Wuhan, China. Meanwhile, the outbreak also drew attention and concern from the World Health Organization (WHO). COVID-19 is another human infectious disease caused by coronavirus. The transmission of COVID-19 is potent and the infection rate is fast. Since there is no specific drug for COVID-19, the treatment is mainly symptomatic supportive therapy. In addition, it should be pointed out that patients with severe illness need more aggressive treatment and meticulous care. Recently, accurate RNA detection has been decisive for the diagnosis of COVID-19. The development of highly sensitive RT-PCR has facilitated epidemiological studies that provide insight into the prevalence, seasonality, clinical manifestations and course of COVID-19 infection. In this review, we summarize the epidemiology and characteristics of COVID-19.
Since December 2019, there has been an outbreak of a novel coronavirus (COVID-19) infection in Wuhan, China. Meanwhile, the outbreak also drew attention and concern from the World Health Organization (WHO). COVID-19 is another humaninfectious disease caused by coronavirus. The transmission of COVID-19 is potent and the infection rate is fast. Since there is no specific drug for COVID-19, the treatment is mainly symptomatic supportive therapy. In addition, it should be pointed out that patients with severe illness need more aggressive treatment and meticulous care. Recently, accurate RNA detection has been decisive for the diagnosis of COVID-19. The development of highly sensitive RT-PCR has facilitated epidemiological studies that provide insight into the prevalence, seasonality, clinical manifestations and course of COVID-19infection. In this review, we summarize the epidemiology and characteristics of COVID-19.
Authors: Negar Moradian; Marjan Moallemian; Farnaz Delavari; Constantine Sedikides; Carlos A Camargo; Pedro J Torres; Armin Sorooshian; Saeid Paktinat Mehdiabadi; Juan J Nieto; Stephane Bordas; Hamid Ahmadieh; Mohammad Abdollahi; Michael R Hamblin; Frank W Sellke; Jack Cuzick; Bozkurt Biykem; Michael Schreiber; Babak Eshrati; Georg Perry; Ali Montazeri; Ali Akbar Saboury; Roya Kelishadi; Amirhossein Sahebkar; Ali A Moosavi-Movahed; Hassan Vatandoost; Mofid Gorji-Bandpy; Bahram Mobasher; Nima Rezaei Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622
Authors: Sanderson José Costa de Assis; Johnnatas Mikael Lopes; Marcello Barbosa Otoni Gonçalves Guedes; Geronimo José Bouzas Sanchis; Diego Neves Araujo; Angelo Giuseppe Roncalli Journal: PLoS One Date: 2021-05-13 Impact factor: 3.240